 |
|
|
| |
Impact of Modest Weight Reduction on Serum Markers, Liver Histology, and Disease Progression in Patients with Advanced Fibrosis due to NASH
|
| |
| |
AASLD 2021 Nov 12-15
Jaime Bosch,1 Stephen A. Harrison,2 Vlad Ratziu,3 Quentin M. Anstee,4 Michael Trauner,5 Eric J. Lawitz,6
Vincent Wai-Sun Wong,7 Takeshi Okanoue,8 Manuel Romero-Gomez,9 Mitchell L. Shiffman,10
Stephen H. Caldwell,11 Lily Ma,12 Dora Ding,12 Ryan S. Huss,12 Chuhan Chung,12 Robert P. Myers,12
Zachary Goodman,13 Nezam H. Afdhal,14 Zobair M. Younossi,13 Arun J. Sanyal15
1Hospital Clinic, University of Barcelona, Spain, and Bern University, Bern, Switzerland; 2Pinnacle Clinical Research, San Antonio, TX, USA; 3Hôpital Pitié-Salpêtrière, Paris, France; 4Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, UK; 5Medical University of Vienna, Vienna, Austria; 6Texas Liver Institute, University of Texas Health, San Antonio, TX; 7The Chinese University of Hong Kong, Hong Kong; 8Saiseikai Suita Hospital, Suita City, Osaka, Japan; 9Hospital Universitario Virgen del Rocio, Sevilla, Spain; 10Bon Secours Liver Institute, Richmond, VA, USA; 11University of Virginia, Charlottesville, VA, USA; 12Gilead Sciences, Inc., Foster City, CA, USA; 13Inova Fairfax Hospital, Falls Church, VA, USA; 14Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA; 15Virginia Commonwealth University, Richmond, VA, USA
|
| |
|
|
|
|
|
